BeStock  

Xeris Pharmaceuticals XERS

US equityMarket cap rank #2408Drug Manufacturers - Specialty & Generic
$16.97 +$0.35 (+2.11%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $17.00 +0.18%
Open$16.61
Prev close$16.62
Day range$16.53 – $17.04
Volume2.86M
Market cap$3.10B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-617.0x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 60.1x

Price / book62.4x
CheapRich

Near the top of its 5-year range · 86th percentile, 5-year average -99.7x

#5275 of 5330 stocks by PB (1 = cheapest)

Price / sales8.3x
CheapRich

Near the top of its 5-year range · 97th percentile, 5-year average 3.6x

#4380 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-849x215x1,279x2,343xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$13.26
Price vs. fair value+28.0%Trading above the estimate
Star rating★★☆☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 62.40 – -99.71 86% (pricier than usual) #5275 of 5330 (1 = cheapest)
PE -617.04 48.74 60.12 0% (cheaper than usual) –
PS 8.27 6.06 3.60 97% (pricier than usual) #4380 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on XERS.

Sign in to join the discussion.

Scroll to Top